CGI’s Proprietary DNA-based Test For Cervical Cancer, FHACT™, Adopted By Leading Kamineni Hospital Group in India For The Diagnosis and Triaging of Cervical Cancer

By Italia on March 20 2014

There are over 123,000 new cervical cancer cases in India each year where it is a leading cause of cancer mortality, causing 17% of deaths in women 30-69 years of age. Adoption of  FHACT™ cervical cancer test by Kamineni Hospitals positions CGI to significantly improve women’s health in India. RUTHERFORD, N.J., Mar. 20, 2014 — Cancer […]

Continue Reading

Cancer Genetics Appoints Edward J. Sitar as Chief Financial Officer

By Italia on March 17 2014

Seasoned Financial Executive Will Support Company’s Continued Growth and Focus on Reimbursement and Payers RUTHERFORD, NJ – March 17, 2014 – Cancer Genetics (NasdaqCM: CGIX), an emerging leader in DNA-based diagnostics, announced today that effective April 1, 2014, it has appointed Edward J. Sitar, CPA as Chief Financial Officer.  Mr. Sitar will be responsible for […]

Continue Reading